These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 4052603
1. [Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)]. Kozlov VK, Filatova LV, Kulikov VI, Markosian RA, Bergel'son LD. Biull Eksp Biol Med; 1985 Oct; 100(10):410-2. PubMed ID: 4052603 [Abstract] [Full Text] [Related]
2. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets]. Muzia GI, Kulikov VI. Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603 [Abstract] [Full Text] [Related]
3. Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses. Blank ML, Cress EA, Lee TC, Malone B, Surles JR, Piantadosi C, Hajdu J, Snyder F. Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):3-20. PubMed ID: 7146619 [Abstract] [Full Text] [Related]
4. Halo lipids. VI. Stimulation of human and rabbit blood platelets by racemic halo analogues of O-alkyl-glycerophosphocholine. Ostermann G, Brachwitz H, Till U. Biomed Biochim Acta; 1984 Oct; 43(3):349-55. PubMed ID: 6743307 [Abstract] [Full Text] [Related]
5. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. Ostermann G, Kertscher HP, Till U. Biomed Biochim Acta; 1985 Oct; 44(2):K17-23. PubMed ID: 4004829 [Abstract] [Full Text] [Related]
6. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. Kulikov VI, Muzya GI. Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178 [Abstract] [Full Text] [Related]
8. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells]. Muzia GI, Orlov SM, Berdyshev EV, Kulikov VI. Biokhimiia; 1994 Jul; 59(7):1054-61. PubMed ID: 7948414 [Abstract] [Full Text] [Related]
9. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group]. Kertscher HP, Ostermann G. Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334 [Abstract] [Full Text] [Related]
11. The enantiomer and the positional isomer of platelet-activating factor. Tence M, Coëffier E, Polonsky J, Benveniste J. Biochim Biophys Acta; 1983 Feb 22; 755(3):526-30. PubMed ID: 6824744 [Abstract] [Full Text] [Related]
12. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives. Keraly CL, Benveniste J. Br J Haematol; 1982 Jun 22; 51(2):313-22. PubMed ID: 7082588 [Abstract] [Full Text] [Related]
13. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position. Karasawa K, Satoh N, Masuda M, Setaka M, Hashimoto K, Ishibashi K, Nojima S. J Biochem; 1991 Nov 22; 110(5):683-7. PubMed ID: 1723729 [Abstract] [Full Text] [Related]
14. Effect of 1-aminoadamantanes on adenine nucleotide and serotonin storage in blood platelets. Wesemann W, Muschalek G, Stöltzing H, von Pusch I, Paul N. Eur J Cell Biol; 1981 Dec 22; 26(1):158-67. PubMed ID: 7327177 [Abstract] [Full Text] [Related]
15. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes]. Kulikov VI, Bergel'son LD. Biokhimiia; 1984 Aug 22; 49(8):1310-5. PubMed ID: 6093897 [Abstract] [Full Text] [Related]
16. Metabolism of 1-O-alkyl-2-acetyl-sn-glycerol by washed rabbit platelets: formation of platelet activating factor. Satouchi K, Oda M, Saito K, Hanahan DJ. Arch Biochem Biophys; 1984 Oct 22; 234(1):318-21. PubMed ID: 6486825 [Abstract] [Full Text] [Related]
17. [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]. Benveniste J, Tencé M, Varenne P, Bidault J, Boullet C, Polonsky J. C R Seances Acad Sci D; 1979 Nov 26; 289(14):1037-40. PubMed ID: 121258 [Abstract] [Full Text] [Related]
18. Platelet activation by platelet aggregation factor from Eisenia foelide. Qian R, Zhou YC, Zhuang QQ. Zhongguo Yao Li Xue Bao; 1994 Sep 26; 15(5):432-5. PubMed ID: 7717070 [Abstract] [Full Text] [Related]
19. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro. Wang LL, Mei QB, Zhao DH, Guo ZA. Acta Pharmacol Sin; 2000 Jul 26; 21(7):623-6. PubMed ID: 11360670 [Abstract] [Full Text] [Related]
20. Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines (unsaturated platelet-activating factor): aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release after incubation with indomethacin. Korth R, Mangold HK, Muramatsu T, Zöllner N. Chem Phys Lipids; 1985 Jan 26; 36(3):209-14. PubMed ID: 4006034 [Abstract] [Full Text] [Related] Page: [Next] [New Search]